Bristol-Pfizer anticlot drug gets key EU approval

November 20, 2012 by The Associated Press

European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.

Eliquis was approved for use in the 27 European Union countries in patients at risk for such clots, called systemic embolisms, or for strokes who have an called atrial fibrillation.

It's the second EU approval for Eliquis, developed by partners Bristol-Myers Squibb Co. and .

Eliquis was approved in the EU in May 2011 for preventing dangerous clots from forming in deep veins after hip or .

The new approval clears the drug for use in far more patients. In Europe alone, about 6 million people have atrial fibrillation. Eliquis is part of a new generation of clot-preventing drugs, but isn't approved in the U.S.

Explore further: Easy-to-use blood thinners likely to replace Coumadin

shares

Related Stories

Easy-to-use blood thinners likely to replace Coumadin

February 6, 2012

Within a few years, a new generation of easy-to-use blood-thinning drugs will likely replace Coumadin for patients with irregular heartbeats who are at risk for stroke, according to a journal article by Loyola University ...

J&J again seeks more approvals for clot blocker

September 7, 2012

(AP)—Johnson & Johnson has given the Food and Drug Administration additional data to on its new anticlotting drug, in a second attempt to get approval for more uses.

Proof of added benefit of apixaban in hip replacement

September 17, 2012

The clot-inhibiting drug apixaban (trade name: Eliquis) was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint. In an early benefit assessment pursuant to the ...

Anti-clot drug recommended for new approval in EU

September 21, 2012

(AP)—Advisers to European Union regulators have recommended approval of a new anti-clotting drug for use by adults with a common irregular heart rhythm that boosts risk of strokes or blood clots, drugmakers Bristol-Myers ...

Recommended for you

New research shows vaccine protection against Zika virus

June 28, 2016

The rapid development of a safe and effective vaccine to prevent the Zika virus (ZIKV) is a global priority, as infection in pregnant women has been shown to lead to fetal microcephaly and other major birth defects. The World ...

Nearly 1 in 3 on Medicare got commonly abused opioids

June 22, 2016

Nearly 12 million Medicare beneficiaries received at least one prescription for an opioid painkiller last year at a cost of $4.1 billion, according to a federal report that shows how common the addictive drugs are in many ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.